Department of Clinical and Experimental Cardiology, Heart Center, Academic Medical Center, University of Amsterdam, Meibergdreef 15, PO Box 22660, 1100 DD Amsterdam, The Netherlands
Department of Medical Physiology, Division Heart & Lungs, University Medical Center Utrecht, Alexander Numan Building 4th floor, Yalelaan 50, 3584CM Utrecht, The Netherlands
Department of Clinical Genetics, Academic Medical Center, Meibergdreef 15, 1100DD Amsterdam, The Netherlands
Department of Biological Sciences, Gilead Sciences, 333 Lakeside Drive, Foster City, CA 94404, USA
Department of Clinical Genetics, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands
Department of Epidemiology, Biostatistics and Bioinformatics, Academic Medical Center, Meibergdreef 15, 1100DD Amsterdam, The Netherlands
Department of Pathology, Academic Medical Center, Meibergdreef 15, 1100DD Amsterdam, The Netherlands
Department of Cardiology, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands
Corresponding author. Tel: +31 20 5663262/5663263, Fax: +31 20 6975458, Email: [email protected]
Mathilde R. Rivaud, John A. Jansen and Pieter G. Postema authors contributed equally to this work.
Present address: Department of Cardiometabolic Disorders, Amgen Inc., 1120 Veterans Blvd, South San Francisco, CA 94080, USA.
Present address: InCarda Therapeutics Inc., 150 Northhill Drive, Brisbane, CA 94005, USA.
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/about_us/legal/notices)
Received November 10, 2017
Received in revised form February 23, 2018
Accepted April 13, 2018
